AI/ML Drug Discovery
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
37
NCT05290493
NB-001 in Children and Adolescents With 22q11 Deletion Syndrome
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 10, 2022
Completion: Jun 9, 2023
Loading map...